GlassScriptPhysician profile
Mackenzie Carey
NPI 1114676533
$1,419.00
in general payments reported to CMS, 2019-2025
14 companies · $351 in 2025
The $351 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $788 · 2024: $280 · 2025: $351.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,419.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,419.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $682.34 | 2023-2025 | |
| Biogen, INC. | $150.25 | 2024-2025 | Zurzuvae |
| Lilly USA, LLC | $125.00 | 2023 | Mounjaro |
| Astellas Pharma US INC | $113.97 | 2023 | Veozah |
| Glaxosmithkline, LLC. | $107.83 | 2023-2025 | Bexsero, Trelegy Ellipta, Arexvy |
| Axsome Therapeutics, INC. | $46.75 | 2024 | Auvelity |
| Astrazeneca Pharmaceuticals LP | $43.19 | 2023-2025 | Breztri, Airsupra |
| Insulet Corporation | $41.95 | 2024 | Omnipod |
| Merck Sharp & Dohme LLC | $29.76 | 2024-2025 | Capvaxive, Gardasil 9, Vaxelis |
| Cranial Technologies, INC | $16.02 | 2024 | Doc Band |
| Hologic Sales and Service, LLC | $15.81 | 2023 | Aptima |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.78 | 2024 | Xifaxan |
| Sanofi Pasteur INC. | $15.42 | 2024 | |
| Dexcom, INC. | $14.93 | 2024 | Dexcom G6 Transmitter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mackenzie Carey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.